title: Thrombolysis of basilar artery occlusion--intra-arterial or intravenous: is there really no difference?
authors.forename: Gernot
authors.initials: G
authors.lastname: Schulte-Altedorneburg
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Reith
authors.forename: Hartmut
authors.initials: H
authors.lastname: Brückmann
authors.forename: Martin
authors.initials: M
authors.lastname: Dichgans
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Mayer
mesh_terms: D001488:Basilar Artery / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007269:Injections, Intra-Arterial / Q000592:standards / Q000706:statistics & numerical data; D007275:Injections, Intravenous / Q000592:standards / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods / Q000592:standards; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014715:Vertebrobasilar Insufficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D005343:Fibrinolytic Agents